Works matching IS 13520504 AND DT 2017 AND VI 24 AND IP 10

Results: 12

Efficacy of 12 or 18 weeks of elbasvir plus grazoprevir with ribavirin in treatment-naïve, noncirrhotic HCV genotype 3-infected patients.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 10, p. 895, doi. 10.1111/jvh.12719

By:

Gane, E.;
Nahass, R.;
Luketic, V.;
Asante‐Appiah, E.;
Hwang, P.;
Robertson, M.;
Wahl, J.;
Barr, E.;
Haber, B.

Publication type:

Article

Entecavir maleate versus entecavir in Chinese chronic hepatitis B predominantly genotype B or C: Results at week 144.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 10, p. 877, doi. 10.1111/jvh.12710

By:

Xu, J.‐H.;
Wang, S.;
Xu, Z.‐N.;
Yu, Y.‐Y.;
Si, C.‐W.;
Zeng, Z.;
Li, J.;
Mao, Q.;
Zhang, D.‐Z.;
Tang, H.;
Sheng, J.‐F.;
Chen, X.‐Y.;
Ning, Q.;
Shi, G.‐F.;
Xie, Q.;
Zhang, X.‐Q.;
Dai, J.

Publication type:

Article

Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 10, p. 858, doi. 10.1111/jvh.12712

By:

Vukotic, R.;
Conti, F.;
Fagiuoli, S.;
Morelli, M. C.;
Pasulo, L.;
Colpani, M.;
Foschi, F. G.;
Berardi, S.;
Pianta, P.;
Mangano, M.;
Donato, M. F.;
Malinverno, F.;
Monico, S.;
Tamè, M.;
Mazzella, G.;
Belli, L. S.;
Viganò, R.;
Carrai, P.;
Burra, P.;
Russo, F. P.

Publication type:

Article

Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 10, p. 850, doi. 10.1111/jvh.12711

By:

Boglione, L.;
Mornese Pinna, S.;
De Nicolò, A.;
Cusato, J.;
Cariti, G.;
Di Perri, G.;
D'Avolio, A.

Publication type:

Article

The impact of hepatitis B virus infection and vaccination on the development of non-Hodgkin lymphoma.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 10, p. 885, doi. 10.1111/jvh.12713

By:

Huang, C.‐E.;
Yang, Y.‐H.;
Chen, Y.‐Y.;
Chang, J.‐J.;
Chen, K.‐J.;
Lu, C.‐H.;
Lee, K.‐D.;
Chen, P.‐C.;
Chen, C.‐C.

Publication type:

Article

HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 10, p. 865, doi. 10.1111/jvh.12714

By:

Papasavvas, E.;
Azzoni, L.;
Yin, X.;
Liu, Q.;
Joseph, J.;
Mackiewicz, A.;
Ross, B.;
Lynn, K. M.;
Jacobson, J. M.;
Mounzer, K.;
Kostman, J. R.;
Montaner, L. J.

Publication type:

Article

No one size fits all-Shortening duration of therapy with direct-acting antivirals for hepatitis C genotype 1 infection.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 10, p. 808, doi. 10.1111/jvh.12734

By:

El Sherif, O.;
Afhdal, N.;
Curry, M.

Publication type:

Article

Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 10, p. 814, doi. 10.1111/jvh.12705

By:

Chew, K. W.;
Bhattacharya, D.;
Horwich, T. B.;
Yan, P.;
McGinnis, K. A.;
Tseng, C.;
Freiberg, M. S.;
Currier, J. S.;
Butt, A. A.

Publication type:

Article

Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 10, p. 823, doi. 10.1111/jvh.12706

By:

Afdhal, N.;
Everson, G. T.;
Calleja, J. L.;
McCaughan, G. W.;
Bosch, J.;
Brainard, D. M.;
McHutchison, J. G.;
De‐Oertel, S.;
An, D.;
Charlton, M.;
Reddy, K. R.;
Asselah, T.;
Gane, E.;
Curry, M. P.;
Forns, X.

Publication type:

Article

HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 10, p. 832, doi. 10.1111/jvh.12707

By:

Steininger, K.;
Boyd, A.;
Dupke, S.;
Krznaric, I.;
Carganico, A.;
Munteanu, M.;
Neifer, S.;
Schuetze, M.;
Obermeier, M.;
Arasteh, K.;
Baumgarten, A.;
Ingiliz, P.

Publication type:

Article

Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 10, p. 840, doi. 10.1111/jvh.12708

By:

Welzel, T. M.;
Hinrichsen, H.;
Sarrazin, C.;
Buggisch, P.;
Baumgarten, A.;
Christensen, S.;
Berg, T.;
Mauss, S.;
Teuber, G.;
Stein, K.;
Deterding, K.;
Bömmel, F.;
Heyne, R.;
John, C.;
Zimmermann, T.;
Lutz, T.;
Schott, E.;
Hettinger, J.;
Kleine, H.;
König, B.

Publication type:

Article

Issue Information.

Published in:: Journal of Viral Hepatitis, 2017, v. 24, n. 10, p. 805, doi. 10.1111/jvh.12603
Publication type:: Article